Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports

CLINICS AND PRACTICE(2023)

引用 0|浏览0
暂无评分
摘要
(1) Background: There is a high burden of poor glycemic control in the Indian population with type 2 diabetes mellitus (T2DM). Currently, the use of metformin sustained-release (SR)-vildagliptin fixed-dose combination (FDC) is very low as compared to metformin immediate-release (IR)-vildagliptin FDC which is associated with higher adverse events (AEs). Here, we present real-world effectiveness of metformin SR-vildagliptin FDC treatment in patients with T2DM; (2) Methods: This retrospective analysis was carried out from the medical records of adult T2DM patients visiting a single study center in India (December 2020-February 2021). A total of 10 patients (aged >= 20 years) were treated with vildagliptin 50 mg and metformin SR 500 mg FDC for 15 days. The treatment response was assessed by the percentage of time spent in the target glucose range (TIR at baseline and 15 days after treatment); (3) Results: The glycated hemoglobin (HbA1c) levels at baseline varied between 6.5% to 12%. The glycemic control improved in 70% of patients (mean increase in TIR: 18.9%). Treatment adherence was 100%. No gastrointestinal symptoms or AEs were reported; (4) Conclusions: Early intervention with metformin SR-vildagliptin FDC in patients with T2DM can ensure therapy compliance in terms of superior efficacy along with safety and tolerability. Key summary points: Early initiation of combination therapy helps in early achievement of glycemic goals; Early initiation of metformin and vildagliptin FDC results in significant glycemic control with good tolerability and compliance; Metformin SR-vildagliptin FDC has lower adverse events, compared to metformin IR-vildagliptin FDC; A case series of ten patients with T2DM treated with metformin SR-vildagliptin FDC is presented to assess the real-world effectiveness of this combination.
更多
查看译文
关键词
glycemic control,sustained-release sustained-release,fixed-dose,real-world
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要